-Lawrence Steinman Researcher Activity Profile

Research Author Detailed Information 

Lawrence Steinman Publication Rate By Year

Lawrence Steinman has published 2 paper(s) in 2006, 28 paper(s) in 2007, 1 paper(s) in 2008, for a total of 31 research publications in total.

Lawrence L Steinman Author Information

LAST NAME: steinman

FIRST NAME: Lawrence

INITIALS: l

AFFILIATION:

Papers

Lawrence Steinman's Publication Record

1. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. Year Published: 2006
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
2. Tolerizing DNA vaccines for autoimmune arthritis. Year Published: 2006
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
3. Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium. Year Published: 2007
Carbohydrate Microarray Laboratory, Stanford University School of Medicine, Stanford, CA, USA. dwang1@stanford.edu
4. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. Year Published: 2007
5. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Year Published: 2007
Center for Neurologic Diseases, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.
6. Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet. Year Published: 2007
Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA. steinman@stanford.edu
7. Statins--treatment option for central nervous system autoimmune disease? Year Published: 2007
Department of Neurology and Program in Immunology, University of California, San Francisco, California 94143, USA.
8. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Year Published: 2007
Montreal Neurological Institute, Montreal, Quebec, Canada.
9. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Year Published: 2007
Department of Neurology and Program in Immunology, University of California, San Francisco, 513 Parnassus Avenue, S-268, San Francisco, California 94143-0435, USA.
10. Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. Year Published: 2007
Division of Medical Oncology, Department of Medicine, Stanford University, Stanford, CA 94305-5151, USA.
11. Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet. Year Published: 2007
Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA. steinman@stanford.edu
12. Statins--treatment option for central nervous system autoimmune disease? Year Published: 2007
Department of Neurology and Program in Immunology, University of California, San Francisco, California 94143, USA.
13. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Year Published: 2007
Montreal Neurological Institute, Montreal, Quebec, Canada.
14. Tryptophan degradation in autoimmune diseases. Year Published: 2007
Department of Neurooncology, University Hospital of Heidelberg, Germany.
15. Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. Year Published: 2007
Department of Plant Biology, Carnegie Institution, Stanford, California, United States of America.
16. Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. Year Published: 2007
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305-5235, USA.
17. Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. Year Published: 2007
Department of Plant Biology, Carnegie Institution, Stanford, California, United States of America.
18. Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. Year Published: 2007
19. Developing a Telephone Assessment of Physical Activity (TAPA) Questionnaire for Older Adults. Year Published: 2007
University of Washington Health Promotion Research Center, University of Washington Department of Family Medicine, 1107 NE 45th St, Suite 200, Seattle, WA 98105. E-mail: cjmayer@u.washington.edu.
20. Treating depression in older adults: challenges to implementing the recommendations of an expert panel. Year Published: 2007
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98104. E-mail: snowden@u.washington.edu.
21. Developing a Telephone Assessment of Physical Activity (TAPA) questionnaire for older adults. Year Published: 2007
University of Washington Health Promotion Research Center, University of Washington Department of Family Medicine, 1107 NE 45th St, Suite 200, Seattle, WA 98105, USA. cjmayer@u.washington.edu
22. Treating depression in older adults: challenges to implementing the recommendations of an expert panel. Year Published: 2007
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98104, USA. snowden@u.washington.edu
23. Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. Year Published: 2007
Department of Plant Biology, Carnegie Institution, Stanford, California, United States of America.
24. Tryptophan degradation in autoimmune diseases. Year Published: 2007
Department of Neurooncology, University Hospital of Heidelberg, Germany.
25. Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet. Year Published: 2007
Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA. steinman@stanford.edu
26. Statins--treatment option for central nervous system autoimmune disease? Year Published: 2007
Department of Neurology and Program in Immunology, University of California, San Francisco, California 94143, USA.
27. Developing a Telephone Assessment of Physical Activity (TAPA) questionnaire for older adults. Year Published: 2007
University of Washington Health Promotion Research Center, University of Washington Department of Family Medicine, 1107 NE 45th St, Suite 200, Seattle, WA 98105, USA. cjmayer@u.washington.edu
28. Treating depression in older adults: challenges to implementing the recommendations of an expert panel. Year Published: 2007
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98104, USA. snowden@u.washington.edu
29. Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. Year Published: 2007
Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
30. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Year Published: 2008
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA.
31. Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. Year Published: 2007
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305-5235, USA.